Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety

scientific article published on 10 November 2019

Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00259-019-04567-2
P698PubMed publication ID31707430

P2093author name stringRanjit Kumar Sahoo
Chandrasekhar Bal
Madhavi Tripathi
Madhav Prasad Yadav
Sanjana Ballal
P433issue4
P921main subjectlutetium-177Q18882670
P304page(s)934-946
P577publication date2019-11-10
P1433published inEuropean Journal of Nuclear Medicine and Molecular ImagingQ15708890
P1476titleBroadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety
P478volume47

Reverse relations

cites work (P2860)
Q89879502A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225
Q89529826Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology

Search more.